港股異動丨水泥股拉昇 華新水泥升超6% 機構指反內卷”水泥業利潤有望改善
港股水泥股集體上升,其中,華新水泥升超6%,中國天瑞水泥、華潤建材科技升超3.3%,中國建材升3%,海螺水泥、西部水泥、金隅集團升2.5%。消息上,高盛認為,中央財經委會議首提治理企業“過度競爭”,標誌“反內卷”政策升級。鋼鐵業5000萬噸減產計劃有望提速,下半年產量或降6%,利潤率或擴大200元/噸;水泥業約22-27%過剩產能面臨淘汰。政策轉向長期產能削減,將推動行業利潤持續改善。據中國水泥協會數據,高盛估算未經授權的過剩熟料產能超過4億噸,約佔行業總產能的18%。此外,基於最低利用率和能耗強度的額外要求,還有2.77-3.77億噸產能面臨退出壓力,佔行業產能的12-17%。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.